Werbung
Werbung

ALZN

ALZN logo

Alzamend Neuro, Inc. Common Stock

2.39
USD
Gesponsert
+0.05
+2.18%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

2.35

-0.04
-1.51%

ALZN Ergebnisberichte

Positives Überraschungsverhältnis

ALZN übertreffen die 8 der letzten 16Schätzungen.

50%

Nächster Bericht

Datum des nächsten Berichts
09. März 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$2.10
Implizierte Änderung von Q2 26 (Revenue/ EPS)
--
/
+600.00%
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+22.81%

Alzamend Neuro, Inc. Common Stock earnings per share and revenue

On 09. Dez. 2025, ALZN reported earnings of -0.30 USD per share (EPS) for Q2 26, beating the estimate of -1.99 USD, resulting in a 84.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -2.10 USD, with revenue projected to reach -- USD, implying an increase of 600.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q2 2026, Alzamend Neuro, Inc. Common Stock reported EPS of -$0.30, beating estimates by 84.96%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.46%, changed from $2.17 before the earnings release to $2.16 the day after.
The next earning report is scheduled for 09. März 2026.
Based on 4 analysts, Alzamend Neuro, Inc. Common Stock is expected to report EPS of -$2.10 and revenue of -- for Q3 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung